Background The relationship between galectin-3 (Gal-3) and coronary artery disease (CAD)
has not been fully elucidated. Aim This study aimed to determine the relationship between …

Coronary artery disease (CAD) is a common atherosclerotic cardiovascular disease
(ASCVD) associated with significant mortality. Galectin-3 is a novel inflammatory factor …

Atherosclerosis is a complex process mediated by leukocytes, macrophages and various
inflammatory markers. Galectin-3 is secreted by activated macrophages and is involved in …

Background This study aimed to investigate the possible role of serum galectin-3 (Gal-3)
levels in the diagnosis and assessment of significant epicardial artery lesions in patients …

Objective—Galectin-3 (Gal-3) can affect atherogenesis by multiple mechanisms, but it
remains scarcely known whether plasma Gal-3 levels predict cardiovascular events in …

Atherosclerosis is a major cause of stroke and cardiovascular diseases, including coronary
artery disease (CAD)[1], and inflammation is known to play a key role in atherosclerosis …

Galectin-3 is a new biomarker that is assumed to reflect fibrogenesis and inflammation. In
this study, we aimed to evaluate the levels of galectin-3 in patients with acute coronary …

Background Levels of galectin-3, a member of a family of soluble β-galactoside-binding
lectins, are reported to be higher in patients with type 2 diabetes mellitus (DM) and …

Abstract Galectin-1, a β-galactoside-binding lectin mediating inflammation and
neovascularization, is reported to attenuate ventricular remodeling after myocardial …

Objectives: Galectin-3 (Gal-3) is involved in cardiac inflammation and fibrosis, and is in use
as a biomarker that indicates increased risk in heart failure. This study examined the …